Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SMDNet: A Self-Training-Aware and Multi-Modal-Adaptive Deep Learning Network for Low-Data Aβ<sub>42</sub> Probe Design and Optimization.

Journal of medicinal chemistry·2026
Same author

Thermostability Prediction Powered by Synergistic Deep Learning at Experimental and Theoretical Levels for Nanobodies.

ACS applied materials & interfaces·2026
Same author

Machine Learning Navigated Allosteric Network to Unveil Biased Allosteric Modulation of GPCRs.

Journal of chemical theory and computation·2025
Same author

Data-Quality-Navigated Machine Learning Strategy with Chemical Intuition to Improve Generalization.

Journal of chemical theory and computation·2024
Same author

Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy.

Journal of chemical information and modeling·2023
Same author

HOPEXGB: A Consensual Model for Predicting miRNA/lncRNA-Disease Associations Using a Heterogeneous Disease-miRNA-lncRNA Information Network.

Journal of chemical information and modeling·2023

Related Experiment Video

Updated: Oct 29, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.8K

Predicting HIV drug resistance using weighted machine learning method at target protein sequence-level.

Qihang Cai1, Rongao Yuan2, Jian He1

  • 1College of Chemistry, Sichuan University, Chengdu, 610064, Sichuan, China.

Molecular Diversity
|July 9, 2021
PubMed
Summary

Predicting human immunodeficiency virus (HIV) drug resistance is vital for effective acquired immune deficiency syndrome (AIDS) treatment. Machine learning models, particularly weighted Random Forest-based Support Vector Machines, show superior performance in identifying resistance mutations.

Keywords:
HIV drug resistancePredictionTarget protein sequencesWeighted machine learning method

More Related Videos

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.5K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

Related Experiment Videos

Last Updated: Oct 29, 2025

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

18.8K
Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.5K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.7K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Machine Learning in Medicine

Background:

  • Acquired immune deficiency syndrome (AIDS) is a critical global health challenge caused by the human immunodeficiency virus (HIV).
  • Rapid HIV mutation leads to drug resistance, complicating treatment despite available antiretroviral therapies.
  • Predicting drug resistance is essential for personalized HIV treatment strategies.

Purpose of the Study:

  • To develop and evaluate machine learning models for predicting HIV drug resistance based on target protein sequence information.
  • To identify key mutated residues contributing to resistance against 21 different HIV drugs.
  • To enhance prediction accuracy by integrating mutation position-specific importance weights.

Main Methods:

  • Utilized physicochemical properties to encode HIV target protein sequences into numerical vectors.
  • Applied Principal Component Analysis (PCA) for feature dimensionality reduction.
  • Compared Random Forest (RF) and Support Vector Machine (SVM) models with various kernels (linear, polynomial, RBF).
  • Integrated RF feature weighting with RBF-based SVM for improved predictive performance.

Main Results:

  • The RF-weighted RBF-based SVM model demonstrated superior performance in predicting HIV drug resistance.
  • 13 out of 21 drug resistance models achieved correlation coefficients (R²) over 0.8, with 3 exceeding 0.9.
  • Position-specific importance analysis identified mutation residues strongly correlated with drug resistance, aligning with existing literature.

Conclusions:

  • The developed machine learning approach, especially the RF-weighted RBF-SVM, is a promising tool for predicting HIV drug resistance.
  • This method can serve as a valuable supplementary tool for guiding treatment decisions, particularly for novel mutations.
  • The study highlights the importance of sequence information and feature weighting in understanding and predicting drug resistance mechanisms in HIV.